In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Indian Army's Air Defense Chief Lieutenant General Sumer Ivan D'Cunha made a big disclosure on Op
A case has been filed against two managers of Aryan Company for the helicopter crash in Gaurimai
No bilateral cricket series has been played between India and Pakistan for a long time. Now, thes
Maharashtra Deputy CM Devendra Fadnavis has said something to allay the concerns about a suspicio
The Central Teacher Eligibility Test (CTET) 2022 to be organized by the Central Board of Secondar
The month of December is nearing its end, while the cold in North India is not taking its name. T
The Hijab controversy, which started in Udupi, Karnataka, has reached the Parliament via the High
Indian women's cricket team vice-captain Smriti Mandhana made her first public appearance since h
Google Pixel 7A launch date revealed phone will be launched this week, know the features and price
Google has prepared to launch its new mid-range phone Google Pixel 7a in India. This phone will b
The fees for MA courses conducted at Pandit Deendayal Upadhyaya Rural Development Institute locat
